Diversity and Evolution in the Genome of Clostridium difficile, Clin Microbiol Rev, vol.28, issue.3, pp.721-762, 2015. ,
Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, Euro Surveill, vol.20, issue.10, p.21059, 2010. ,
Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach, BMC Infect Dis, vol.16, p.303, 2016. ,
Can we identify patients at high risk of recurrent Clostridium difficile infection?, Clin Microbiol Infect, vol.18, issue.6, pp.21-28, 2012. ,
Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study, J Hosp Infect, vol.93, issue.3, pp.286-295, 2016. ,
European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection, Clin Microbiol Infect, issue.2, pp.1-26, 1920. ,
Duodenal infusion of donor feces for recurrent Clostridium difficile, N Engl J Med, vol.368, issue.5, pp.407-422, 2013. ,
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection, Aliment Pharmacol Ther, vol.41, issue.9, pp.835-878, 2015. ,
Economic studies part I: basics and terms. Evid-Based Spine-Care J, vol.3, pp.7-11, 2012. ,
Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis, Clin Infect Dis, vol.58, issue.11, pp.1507-1521, 2014. ,
Is fidaxomicin worth the cost? An economic analysis, Clin Infect Dis, vol.57, issue.4, pp.555-61, 2013. ,
Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States, Value Health J Int Soc Pharmacoeconomics Outcomes Res, vol.16, issue.2, pp.297-304, 2013. ,
Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology, vol.142, pp.490-496, 2012. ,
Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology, J Clin Gastroenterol, vol.44, issue.8, pp.567-70, 2010. ,
Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients, J Clin Gastroenterol, vol.44, issue.8, pp.562-568, 2010. ,
Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series, Anaerobe, vol.19, pp.22-28, 2013. ,
Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube, Clin Infect Dis, vol.36, issue.5, pp.580-585, 2003. ,
Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection, Arch Intern Med, vol.172, issue.2, pp.191-194, 2012. ,
Success of self-administered home fecal transplantation for chronic Clostridium difficile infection, Clin Gastroenterol Hepatol, vol.8, issue.5, pp.471-474, 2010. ,
Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients, Lancet Lond Engl, vol.1, issue.8648, pp.1156-60, 1989. ,
Hospital-acquired Clostridium difficile infection: determinants for severe disease, Eur J Clin Microbiol Infect Dis, vol.31, issue.8, pp.1923-1953, 2012. ,
Timing of surgery for fulminating pseudomembranous colitis, Br J Surg, vol.85, issue.2, pp.229-260, 1998. ,
Colectomy for fulminant Clostridium difficile colitis: predictors of mortality, Am Surg, vol.76, issue.4, pp.418-439, 2010. ,
Predictors of mortality after colectomy for fulminant Clostridium difficile colitis, Arch Surg Chic Ill, vol.143, issue.2, pp.150-154, 1960. ,
, Complications of colonoscopy. Gastrointest Endosc, vol.74, issue.4, pp.745-52, 2011.
Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, vol.15, pp.371-81, 1982. ,
Canadian Hospital Epidemiology Committee. Canadian Nosocomial Infection Surveillance Program. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals, Infect Control Hosp Epidemiol, vol.23, issue.3, pp.137-177, 2002. ,
A review of mortality due to Clostridium difficile infection, J Infect, vol.61, issue.1, pp.1-8, 2010. ,
Is laparoscopic colectomy for cancer cost-effective relative to open colectomy?, ANZ J Surg, vol.77, issue.9, pp.782-788, 2007. ,
Avoiding or reversing Hartmann's procedure provides improved quality of life after perforated diverticulitis, J Gastrointest Surg, vol.14, issue.4, pp.651-658, 2010. ,
Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study, Clin Infect Dis, vol.58, issue.11, pp.1515-1537, 2014. ,
Endoscopic peroral jejunal fecal microbiota transplantation. Dig Liver Dis, 2016. ,
Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis, Am J Gastroenterol, vol.108, issue.4, pp.500-508, 2013. ,
, WHO Commission on Macroeconomics and Health. Macroeconomics and health: investing in health for economic development, 2001.
, Insee-Tableau-1.115-Produit intérieur brut et revenu national brut par habitant (Milliers de personnes, Milliards d'euros et Euros par personne
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, Value Health J Int Soc Pharmacoeconomics Outcomes Res, vol.16, issue.2, pp.1-5, 2013. ,
Faecal microbiota transplantation for Clostridium difficile infection, Int J Clin Pract, vol.68, issue.3, pp.363-371, 2014. ,
Intestinal Microbiota and the Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Disease, Gastroenterol Hepatol, vol.10, issue.4, pp.230-237, 2014. ,
A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin. Microbiol Read Engl, vol.156, pp.3354-3363, 2010. ,
Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients, J Infect Chemother, vol.21, issue.4, pp.230-237, 2015. ,
Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients, Am J Gastroenterol, vol.109, issue.7, pp.1065-71, 2014. ,
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial, JAMA, vol.315, issue.2, pp.142-151, 2016. ,